Algorand

by Algorand

(0)
View Profile

IOST

by IOST

(0)
View Profile

Veritaseum

by Veritaseum

(0)
View Profile

Algorand

by Algorand

(0)
View Profile

IOST

by IOST

(0)
View Profile

Veritaseum

by Veritaseum

(0)
View Profile

What problem does this service solve?

Algorand's goal is to create a blockchain with faster transaction times and a more inclusive staking mechanism to achieve consensus.The Internet of Services Token is focused on improving overall blockchain speed and performance.Veritaseum provides blockchain-based software solutions for financial clients. Their network makes it easier for clients to create their own sub-tokens and decentralized applications to interact with capital markets.

Token Stats

Company Description

Algorand is a Boston based company that is developing a blockchain network with a Pure Proof of Stake (PPoS) consensus mechanism. Algorand's decentralized platform is designed to enable faster transaction times and remove some of the technical barriers of creating scalable DApps. Algorand was founded by Silvio Micali, a pioneer in the field of cryptography.

IOST (Internet of Services Token) is a blockchain platform that is focused on improving transaction speed and scalability. IOST has a unique Proof of Believability consensus mechanism that is based on past contributions and behavior.
The company claims that their platform will increase security and efficiency compared to other platforms. IOST uses a sharding technique that splits the network into smaller ones and randomly assigns tasks for the nodes on the network.

Veritaseum develops blockchain-based software solutions for capital markets. Their goal is to decentralize access to these markets, with both centralized and decentralized solutions, for a range of financial institutions. The company assists their clients in building bespoke decentralized applications. Veritaseum's software solutions are built upon their platform, which allows for the creation of Veritas sub-tokens that serve the specific needs of the client.

Ratings

(0)

(0)

(0)